Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

digital marketing executive

- PMLiVE

AstraZeneca’s Calquence combination shows promise in untreated mantle cell lymphoma

The rare form of non-Hodgkin lymphoma is estimated to affect more than 27,500 people globally

- PMLiVE

Johnson & Johnson shares positive results for TAR-200 in high-risk bladder cancer

More than 83,000 cases of bladder cancer are diagnosed in the US every year

- PMLiVE

Uptake Honoured in King’s Awards for Enterprise 2024

The global healthcare consultancy is awarded for outstanding international growth in the International Trade category

- PMLiVE

Achieving patient-guided drug development: putting the patient experience first

Why understanding all aspects of the patient journey is imperative to successful clinical research

- PMLiVE

NHS primary care panel – the GP Contract and Operational Planning Guidance – Live Webinar

What can we expect to see in primary care in the NHS given recent policy announcements and ongoing uncertainty? What does the new GP Contract tell us about the future...

Mtech Access

- PMLiVE

Word Monster and the PM Society join forces to elevate medical writing standards

Both partners aim to improve training and foster innovation in the medical communications industry

- PMLiVE

Free Live Webinar – Uniting Communities for Rare Disease Clinical Trial Success

Join this live webinar focusing on patient recruitment and retention in rare disease trials.

Innovative Trials

- PMLiVE

Sanofi/Sobi’s efanesoctocog alfa recommended by CHMP to treat haemophilia A

The rare genetic condition reduces production of factor VIII, an essential protein for blood clotting

- PMLiVE

Tiziana shares promising results for intranasal foralumab in multiple sclerosis

The neurological disease affects approximately 2.8 million people worldwide

- PMLiVE

New immune cell discovery could lead to personalised breast cancer treatments

The study revealed the key features of immune cells in helping the body’s immune system fight cancer

- PMLiVE

Supercharged strategies: it’s time for pharma to get brave and bold

The importance of putting boldness front and centre

- PMLiVE

Navigating the rapidly changing oncology treatment landscape: how digital tools can help

With rapid growth comes growing pains...

Impetus Digital

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links